{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:35:10Z","timestamp":1769067310961,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Modern radiotherapy (RT) reduces the side effects at organ at risk. However, skin toxicity is still a major problem in many entities, especially head and neck cancer. Some substances like chemotherapy provide a risk of increased side effects or can induce a \"recall phenomenon\" imitating acute RT-reactions months after RT. Moreover, some phototoxic drugs seem to enhance side effects of radiotherapy while others do not. We report a case of \"radiation recall dermatitis\" (RRD) one year after RT as a result of taking hypericin (St. John's wort).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case report<\/jats:title>\n            <jats:p>A 65 year old man with completely resected squamous cell carcinoma of the epiglottis received an adjuvant locoregional RT up to a dose of 64.8 Gy. The patient took hypericin during and months after RT without informing the physician. During radiotherapy the patient developed unusual intensive skin reactions. Five months after RT the skin was completely bland at the first follow up. However, half a year later the patient presented erythema, but only within the area of previously irradiated skin. After local application of a steroid cream the symptoms diminished but returned after the end of steroid therapy. The anamnesis disclosed that the patient took hypericin because of depressive mood. We recommended to discontinue hypericin and the symptoms disappeared afterward.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Several drugs are able to enhance skin toxicity of RT. Furthermore, the effect of RRD is well known especially for chemotherapy agents such as taxans. However, the underlying mechanisms are not known in detail so far. Moreover, it is unknown whether photosensitising drugs can also be considered to increase radiation sensitivity and whether a recall phenomenon is possible. The first report of a hypericin induced RRD and review of the literature are presented. In clinical practise many interactions between drugs and radiotherapy were not noticed and if registered not published. We recommend to ask especially for complementary or alternative drugs because patients tend to conceal such medication as harmless.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-1-32","type":"journal-article","created":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T19:04:20Z","timestamp":1157137460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy \u2013 case report and review of literature"],"prefix":"10.1186","volume":"1","author":[{"given":"Kurt","family":"Putnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF03038718","volume":"174","author":"T Kuhnt","year":"1998","unstructured":"Kuhnt T, Richter C, Enke H, Dunst J: Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol 1998, 174: 257-261.","journal-title":"Strahlenther Onkol"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00066-003-1106-0","volume":"179","author":"T Kuhnt","year":"2003","unstructured":"Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, et al.: Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlenther Onkol 2003, 179: 673-681. 10.1007\/s00066-003-1106-0","journal-title":"Strahlenther Onkol"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00066-003-1142-9","volume":"179","author":"F Momm","year":"2003","unstructured":"Momm F, Weissenberger C, Bartelt S, Henke M: Moist skin care can diminish acute radiation-induced skin toxicity. Strahlenther Onkol 2003, 179: 708-712. 10.1007\/s00066-003-1142-9","journal-title":"Strahlenther Onkol"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s00066-003-1158-1","volume":"179","author":"A Schuck","year":"2003","unstructured":"Schuck A, Biermann M, Pixberg MK, Muller SB, Heinecke A, Schober O, et al.: Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS). Strahlenther Onkol 2003, 179: 832-839. 10.1007\/s00066-003-1158-1","journal-title":"Strahlenther Onkol"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/PL00002431","volume":"177","author":"BU Giesel","year":"2001","unstructured":"Giesel BU, Kutz GG, Thiel HJ: [Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature]. Strahlenther Onkol 2001, 177: 487-493. 10.1007\/PL00002431","journal-title":"Strahlenther Onkol"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00001622-200203000-00012","volume":"14","author":"E Alley","year":"2002","unstructured":"Alley E, Green R, Schuchter L: Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002, 14: 212-216. 10.1097\/00001622-200203000-00012","journal-title":"Curr Opin Oncol"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1085-5629(99)80026-1","volume":"18","author":"JH Epstein","year":"1999","unstructured":"Epstein JH: Phototoxicity and photoallergy. Semin Cutan Med Surg 1999, 18: 274-284. 10.1016\/S1085-5629(99)80026-1","journal-title":"Semin Cutan Med Surg"},{"key":"32_CR8","first-page":"1401","volume":"23","author":"HY Du","year":"2003","unstructured":"Du HY, Olivo M, Tan BK, Bay BH: Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol 2003, 23: 1401-1405.","journal-title":"Int J Oncol"},{"key":"32_CR9","first-page":"2579","volume":"20","author":"AR Kamuhabwa","year":"2000","unstructured":"Kamuhabwa AR, Agostinis P, D'Hallewin MA, Kasran A, de Witte PA: Photodynamic activity of hypericin in human urinary bladder carcinoma cells. Anticancer Res 2000, 20: 2579-2584.","journal-title":"Anticancer Res"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","volume":"59","author":"R Camidge","year":"2001","unstructured":"Camidge R, Price A: Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001, 59: 237-245. 10.1016\/S0167-8140(01)00328-0","journal-title":"Radiother Oncol"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/028418699432653","volume":"38","author":"A Bostrom","year":"1999","unstructured":"Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J: Radiation recall \u2013 another call with tamoxifen. Acta Oncol 1999, 38: 955-959. 10.1080\/028418699432653","journal-title":"Acta Oncol"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2000.18.3.695","volume":"18","author":"D Castellano","year":"2000","unstructured":"Castellano D, Hitt R, Cortes-Funes H, Romero A, Rodriguez-Peralto JL: Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000, 18: 695-696.","journal-title":"J Clin Oncol"},{"key":"32_CR13","unstructured":"Rote Liste Win\n                    \u00ae\n                  2005\/I. [4.1]. Rote Liste Service GmbH, ECV Editio Cantor Verlag Ref Type: Computer Program"},{"key":"32_CR14","first-page":"34S","volume":"20","author":"LM Digianni","year":"2002","unstructured":"Digianni LM, Garber JE, Winer EP: Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002, 20: 34S-38S.","journal-title":"J Clin Oncol"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O","volume":"83","author":"E Ernst","year":"1998","unstructured":"Ernst E, Cassileth BR: The prevalence of complementary\/alternative medicine in cancer: a systematic review. Cancer 1998, 83: 777-782. 10.1002\/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O","journal-title":"Cancer"},{"key":"32_CR16","first-page":"71","volume":"58","author":"M Blumenthal","year":"2003","unstructured":"Blumenthal M: Herbs continue slide in mainstream market: Sales down 14 percent. HerbalGram 2003, 58: 71.","journal-title":"HerbalGram"},{"key":"32_CR17","first-page":"36","volume":"Jul\/Aug","author":"J Gruenwald","year":"2000","unstructured":"Gruenwald J: The supplement markets in the US and Europe. Neutraceuticals World 2000, Jul\/Aug: 36-37.","journal-title":"Neutraceuticals World"},{"key":"32_CR18","volume-title":"Pharma-Daten, 34. \u00fcberarbeitete Auflage edn","author":"Bundesverband der Pharmazeutischen Industrie e.V.(BPI)","year":"2004","unstructured":"Bundesverband der Pharmazeutischen Industrie e.V.(BPI): Pharma-Daten, 34. \u00fcberarbeitete Auflage edn. Hamburg: Netrixx Communications GmbH; 2004."},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1592\/phco.20.1.83.34658","volume":"20","author":"TB Klepser","year":"2000","unstructured":"Klepser TB, Doucette WR, Horton MR, Buys LM, Ernst ME, Ford JK, et al.: Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000, 20: 83-87. 10.1592\/phco.20.1.83.34658","journal-title":"Pharmacotherapy"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2642::AID-CNCR8>3.0.CO;2-4","volume":"86","author":"MC Lippert","year":"1999","unstructured":"Lippert MC, McClain R, Boyd JC, Theodorescu D: Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 1999, 86: 2642-2648. 10.1002\/(SICI)1097-0142(19991215)86:12<2642::AID-CNCR8>3.0.CO;2-4","journal-title":"Cancer"},{"key":"32_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","volume":"280","author":"DM Eisenberg","year":"1998","unstructured":"Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van RM, et al.: Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey. JAMA 1998, 280: 1569-1575. 10.1001\/jama.280.18.1569","journal-title":"JAMA"},{"key":"32_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00228-004-0784-6","volume":"60","author":"K Rieger","year":"2004","unstructured":"Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, et al.: High prevalence of unknown co-medication in hospitalised patients. Eur J Clin Pharmacol 2004, 60: 363-368. 10.1007\/s00228-004-0784-6","journal-title":"Eur J Clin Pharmacol"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2125.2004.02169.x","volume":"58","author":"M Martin-Facklam","year":"2004","unstructured":"Martin-Facklam M, Rieger K, Riedel KD, Burhenne J, Walter-Sack I, Haefeli WE: Undeclared exposure to St. John's Wort in hospitalized patients. Br J Clin Pharmacol 2004, 58: 437-441. 10.1111\/j.1365-2125.2004.02169.x","journal-title":"Br J Clin Pharmacol"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998, 279: 1200-1205. 10.1001\/jama.279.15.1200","journal-title":"JAMA"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1081\/DMR-120018248","volume":"35","author":"S Zhou","year":"2003","unstructured":"Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW: Interactions of herbs with cytochrome P450. Drug Metab Rev 2003, 35: 35-98. 10.1081\/DMR-120018248","journal-title":"Drug Metab Rev"},{"key":"32_CR26","first-page":"CD000448","volume-title":"Cochrane Database Syst Rev","author":"K Linde","year":"2005","unstructured":"Linde K, Mulrow CD, Berner M, Egger M: St John's wort for depression. Cochrane Database Syst Rev 2005, CD000448."},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1200\/JCO.2004.08.182","volume":"22","author":"A Sparreboom","year":"2004","unstructured":"Sparreboom A, Cox MC, Acharya MR, Figg WD: Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004, 22: 2489-2503. 10.1200\/JCO.2004.08.182","journal-title":"J Clin Oncol"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1001\/archinte.160.16.2548","volume":"160","author":"TO Cheng","year":"2000","unstructured":"Cheng TO: St John's wort interaction with digoxin. Arch Intern Med 2000, 160: 2548. 10.1001\/archinte.160.16.2548","journal-title":"Arch Intern Med"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1345\/aph.18252","volume":"33","author":"A Nebel","year":"1999","unstructured":"Nebel A, Schneider BJ, Baker RK, Kroll DJ: Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 1999, 33: 502. 10.1345\/aph.18252","journal-title":"Ann Pharmacother"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0140-6736(05)73359-6","volume":"355","author":"T Breidenbach","year":"2000","unstructured":"Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J: Drug interaction of St John's wort with cyclosporin. Lancet 2000, 355: 1912. 10.1016\/S0140-6736(05)73359-6","journal-title":"Lancet"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2125.2003.01716.x","volume":"55","author":"UI Schwarz","year":"2003","unstructured":"Schwarz UI, Buschel B, Kirch W: Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 2003, 55: 112-113. 10.1046\/j.1365-2125.2003.01716.x","journal-title":"Br J Clin Pharmacol"},{"key":"32_CR32","first-page":"535","volume":"16","author":"S Bon","year":"1999","unstructured":"Bon S, Hartmann K, Kuhn M: Johanniskraut: Ein Enzymeinduktor? Schweizer Apothekerzeitung 1999, 16: 535-536.","journal-title":"Schweizer Apothekerzeitung"},{"key":"32_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0140-6736(05)73227-X","volume":"355","author":"QY Yue","year":"2000","unstructured":"Yue QY, Bergquist C, Gerden B: Safety of St John's wort (Hypericum perforatum). Lancet 2000, 355: 576-577. 10.1016\/S0140-6736(05)73227-X","journal-title":"Lancet"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/026988110001400113","volume":"14","author":"DM Barbenel","year":"2000","unstructured":"Barbenel DM, Yusufi B, O'Shea D, Bench CJ: Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline. J Psychopharmacol 2000, 14: 84-86.","journal-title":"J Psychopharmacol"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1751-0813.2004.tb12165.x","volume":"82","author":"CA Bourke","year":"2004","unstructured":"Bourke CA, White JG: Reassessment of the toxicity of Hypericum perforatum (St John's wort) for cattle. Aust Vet J 2004, 82: 707-710.","journal-title":"Aust Vet J"},{"key":"32_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.7326\/0003-4819-136-1-200201010-00010","volume":"136","author":"E Ernst","year":"2002","unstructured":"Ernst E: The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002, 136: 42-53.","journal-title":"Ann Intern Med"},{"key":"32_CR37","first-page":"1099","volume":"18","author":"I Zupko","year":"2001","unstructured":"Zupko I, Kamuhabwa AR, D'Hallewin MA, Baert L, de Witte PA: In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors. Int J Oncol 2001, 18: 1099-1105.","journal-title":"Int J Oncol"},{"key":"32_CR38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2133.2005.06946.x","volume":"153","author":"PE Beattie","year":"2005","unstructured":"Beattie PE, Dawe RS, Traynor NJ, Woods JA, Ferguson J, Ibbotson SH: Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy? Br J Dermatol 2005, 153: 1187-1191. 10.1111\/j.1365-2133.2005.06946.x","journal-title":"Br J Dermatol"},{"key":"32_CR39","first-page":"843","volume":"2","author":"W Zhang","year":"1996","unstructured":"Zhang W, Anker L, Law RE, Hinton DR, Gopalakrishna R, Pu Q, et al.: Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. Clin Cancer Res 1996, 2: 843-846.","journal-title":"Clin Cancer Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-1-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:45:18Z","timestamp":1630453518000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-1-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-1-32","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,1]]},"assertion":[{"value":"11 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}